12:00 AM
 | 
May 12, 2014
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Greer, Stallergenes sales and marketing update

Greer launched Oralair in the U.S. to treat grass pollen-induced allergic rhinitis with or without conjunctivitis in people aged 10-65 years. The wholesale acquisition cost is $10...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >